United States District Court
Middle District of Florida

The schedule is subject to change. Because the schedule is provided as public information only, it is not intended to serve as notice to any party.
This page was last updated on September 17, 2021 at 09:45.


The Honorable Roy B. Dalton, Jr.
Hearings Calendar

September 27 to October 1, 2021

Monday

Date Time Case No. DE # Party Hearing Type
09/27/2021
No Scheduled Court Activity

Tuesday

Date Time Case No. DE # Party Hearing Type
09/28/2021  10:00  6:21-cv-01287-RBD-DAB  44  Merced et al v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01299-RBD-DAB  16  Schimming et al v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01300-RBD-DAB  38  Pederson v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01301-RBD-DAB  28  Becker v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01302-RBD-DAB  35  Witt v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01304-RBD-DAB  48  Gustin et al v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01305-RBD-DAB  48  Dean v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01309-RBD-DAB  39  Poitra v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01310-RBD-DAB  23  Isaacson v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01312-RBD-DAB  30  Giancaspro v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01313-RBD-DAB  58  Hurd v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01315-RBD-DAB  50  Garland v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01320-RBD-DAB  37  Craig v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01327-RBD-DAB  76  Colella v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01335-RBD-DAB  54  Tonge v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01336-RBD-DAB  36  Lally v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01371-RBD-DAB  31  Davis v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01374-RBD-DAB  51  Burke v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01389-RBD-DAB  Miller et al v. Novartis Pharmaceuticals Corporation  Status Conference 
09/28/2021  10:00  6:21-cv-01408-RBD-DAB  19  Riley v. Novartis Pharmaceutical Corporation  Status Conference 
09/28/2021  10:00  6:21-md-03006-RBD-DAB  In Re: Tasigna (Nilotinib) Products Liability Litigation  Status Conference 

Wednesday

Date Time Case No. DE # Party Hearing Type
09/29/2021
No Scheduled Court Activity

Thursday

Date Time Case No. DE # Party Hearing Type
09/30/2021
No Scheduled Court Activity

Friday

Date Time Case No. DE # Party Hearing Type
10/01/2021
No Scheduled Court Activity